DIABETES CONTROL THROUGH TECHNOLOGY

That this House commends the work of the diabetes team in Ealing in assessing the impact of intensive injection technique education and the use of a 4mm 32G pen needle on diabetes control; calls on clinical commissioning groups and other healthcare providers across the country to give people with diabetes choice over the technology they use and appropriate training in diabetes management skills; notes that use of poor quality technology can lead to increased pain and discomfort; is deeply concerned that patients who are multiple daily injectors are having the choice of the needle that they use taken away from them; and further notes the important role that innovative technologies play in supporting patients to lead full and active lives.